Inventor · disambiguated record
Virginie Sophie Poncelet
Also filed as: PONCELET VIRGINIE S · PONCELET VIRGINIE SOPHIE
37 granted patents·9 pending applications·536 citations·filing 1998–2022
97Inventor score
Files withJANSSEN PHARMACEUTICA NV25ASTEX THERAPEUTICS LTD7EMELEN KRISTOF VAN3ANGIBAUD PATRICK RENE2FREYNE EDDY JEAN EDGARD2
Top patents by PatentIndex Score
46 records- 0197US7709487B2Sulfonyl-derivatives as novel inhibitors of histone deacetylaseJANSSEN PHARMACEUTICA NV·Filed 2007·Granted May 4, 2010·53 cites·8 claims
- 0297US6187786B1Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazolesJANSSEN PHARMACEUTICA NV·Filed 1998·Granted Feb 13, 2001·119 cites·11 claims
- 0396US7704998B2Sulfonyl-derivatives as novel inhibitors or histone deacetylaseJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Apr 27, 2010·39 cites·8 claims
- 0496US7541369B2Amino-derivatives as novel inhibitors of histone deacetylaseJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Jun 2, 2009·54 cites·6 claims
- 0595US9447098B2Pteridines as FGFR inhibitorsASTEX THERAPEUTICS LTD·Filed 2013·Granted Sep 20, 2016·35 cites·20 claims
- 0695US7205304B2Sulfonyl-Derivatives as novel inhibitors of histone deacetylaseJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Apr 17, 2007·54 cites·12 claims
- 0794US9309242B2Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2012·Granted Apr 12, 2016·26 cites·28 claims
- 0894US9303029B2Substituted quinoxalines as FGFR kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2012·Granted Apr 5, 2016·25 cites·20 claims
- 0992US10052320B2Substituted quinoxalines as FGFR kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2016·Granted Aug 21, 2018·11 cites·20 claims
- 1092US10045982B2Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2016·Granted Aug 14, 2018·11 cites·33 claims
- 1192US9493426B2Quinazolinone derivatives useful as FGFR kinase modulatorsASTEX THERAPEUTICS LTD·Filed 2014·Granted Nov 15, 2016·20 cites·20 claims
- 1289US8288377B2Inhibitors of the interaction between MDM2 and p53STORCK PIERRE-HENRI·Filed 2008·Granted Oct 16, 2012·23 cites·15 claims
- 1388US8299256B2Quinolinone derivatives as PARP and TANK inhibitorsVIALARD JORGE EDUARDO·Filed 2008·Granted Oct 30, 2012·17 cites·9 claims
- 1486US8865720B2Sulfonyl-derivatives as novel inhibitors of histone deacetylaseEMELEN KRISTOF VAN·Filed 2013·Granted Oct 21, 2014·6 cites·12 claims
- 1585US10272087B2Pteridines as FGFR inhibitorsASTEX THERAPEUTICS LTD·Filed 2016·Granted Apr 30, 2019·5 cites·21 claims
- 1685US8524711B2Amino-derivatives as novel inhibitors of histone deacetylaseANGIBAUD PATRICK RENE·Filed 2012·Granted Sep 3, 2013·4 cites·10 claims
- 1784US7799772B2Pyrido-and pyrimidopyrimidine derivatives as anti-profilerative agentsJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Sep 21, 2010·16 cites·6 claims
- 1883US11396517B1Exo-aza spiro inhibitors of menin-MLL interactionJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Jul 26, 2022·6 cites·13 claims
- 1979US8097611B2Sulfonyl-derivatives as novel or histone deacetylaseEMELEN KRISTOF VAN·Filed 2010·Granted Jan 17, 2012·3 cites·12 claims
- 2075US11583524B2Inhibitors of the interaction between MDM2 and P53JANSSEN PHARMACEUTICA NV·Filed 2019·Granted Feb 21, 2023·0 cites·21 claims
- 2175US8778966B2Quinolinone derivatives as PARP and tank inhibitorsVIALARD JORGE EDUARDO·Filed 2012·Granted Jul 15, 2014·3 cites·6 claims
- 2273US8557825B2Sulfonyl-derivatives as novel inhibitors of histone deacetylaseEMELEN KRISTOF VAN·Filed 2011·Granted Oct 15, 2013·1 cites·9 claims
- 2371US2009227558A1Amino-derivatives as novel inhibitors of histone deacetylaseANGIBAUD PATRICK RENE·Filed 2009·Application pending·0 cites
- 2470US9533979B2Amino-derivatives as novel inhibitors of histone deacetylaseJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jan 3, 2017·0 cites·11 claims
- 2568US9573933B2Inhibitors of the interaction between MDM2 and P53PONCELET VIRGINIE SOPHIE·Filed 2008·Granted Feb 21, 2017·1 cites·12 claims
- 2667US8916554B2Amino-derivatives as novel inhibitors of histone deacetylaseJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Dec 23, 2014·0 cites·11 claims
- 2765US7153958B2Farnesyl transferase inhibiting benzoheterocyclic derivativesJANSSEN PHARMACEUTICA NV·Filed 2001·Granted Dec 26, 2006·2 cites·36 claims
- 2864US6444812B1Intermediate compounds in the preparation of farnnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N-or C linked imidazolesJANSSEN PHARMACEUTICA NV·Filed 2000·Granted Sep 3, 2002·2 cites·2 claims
- 2960US2018263966A1Inhibitors Of The Interaction Between MDM2 And P53JANSSEN PHARMACEUTICA NV·Filed 2018·Application pending·0 cites
- 3059US8933067B2Pyrido and pyrimidopyrimidine derivatives as anti-profilerative agentsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jan 13, 2015·0 cites·8 claims
- 3158US10208062B2Macrocyclic quinazole derivatives and their use as MTKIJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Feb 19, 2019·0 cites·2 claims
- 3257US2023039917A1Exo-aza spiro inhibitors of menin-mll interactionJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 3356US2017112818A1Inhibitors of the interaction between mdm2 and p53JANSSEN PHARMACEUTICA NV·Filed 2017·Application pending·0 cites
- 3455US2024417405A1Substituted Spiro DerivativesJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 3553US9688691B2Macrocyclic quinazole derivatives and their use as MTKIJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jun 27, 2017·0 cites·25 claims
- 3652US2006135769A1Farnesyl transferase inhibiting 4-heterocyclyl-quinoline and quinazoline derivativesANGIBAUD PATRICK R·Filed 2006·Application pending·0 cites
- 3751US8853406B2Substituted phenylenediamines as inhibitors of the interaction between MDM2 and P53PONCELET ALAIN PHILIPPE·Filed 2008·Granted Oct 7, 2014·0 cites·9 claims
- 3851US8772272B2Pyrido-and pyrimidopyrimidine derivatives as anti-proliferative agentsFREYNE EDDY JEAN EDGARD·Filed 2010·Granted Jul 8, 2014·0 cites·3 claims
- 3948US11236084B2Substituted azaindoline derivatives as NIK inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Feb 1, 2022·0 cites·15 claims
- 4046US2010152174A1Macrocyclic quinazole derivatives and their use as mtkiFREYNE EDDY JEAN EDGARD·Filed 2005·Application pending·0 cites
- 4145US2013005769A1Inhibitors of the interaction between mdm2 and p53STORCK PIERRE HENRI·Filed 2012·Application pending·0 cites
- 4239US11180487B2Substituted cyanoindoline derivatives as NIK inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Nov 23, 2021·0 cites·15 claims
- 4339US2019263804A1Azabenzimidazole derivatives as pi3k beta inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Application pending·0 cites
- 4438US10894793B2Bicyclic pyridine, pyrazine, and pyrimidine derivatives as PI3K beta inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jan 19, 2021·0 cites·5 claims
- 4535US10202387B2Heterocyclyl linked imidazopyridazine derivatives as PI3KB inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Feb 12, 2019·0 cites·14 claims
- 4635US10087187B2Imidazopyridazine derivatives as PI3KB inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Oct 2, 2018·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Virginie Sophie Poncelet files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →